Gengxin Chen

Title: Gengxin Chen: Innovator in Genetic Analysis

Introduction

Gengxin Chen is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of genetic analysis, particularly in the area of copy number variations (CNVs). With a total of 3 patents, his work has implications for various medical conditions.

Latest Patents

One of Gengxin Chen's latest patents focuses on using cell-free DNA fragment size to determine copy number variations. This patent discloses methods for determining CNVs that are known or suspected to be associated with a variety of medical conditions. In some embodiments, the methods provided allow for the determination of copy number variation of fetuses using maternal samples that comprise both maternal and fetal cell-free DNA. The patent also outlines ways to improve the sensitivity and specificity of sequence data analysis by deriving a fragment size parameter. Various implementations utilize information from fragments of different sizes to evaluate CNVs, and combine t-statistics obtained from coverage information to enhance the evaluation process.

Career Highlights

Gengxin Chen has worked with prominent companies in the biotechnology sector, including Verinata Health, Inc. and Life Technologies Corporation. His experience in these organizations has contributed to his expertise in genetic research and innovation.

Collaborations

Throughout his career, Gengxin has collaborated with notable professionals in the field, including Sven Duenwald and David A Comstock. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Gengxin Chen's innovative approaches to genetic analysis and his contributions to understanding copy number variations highlight his importance in the field. His patents and collaborations reflect a commitment to advancing medical science through technology.